News Focus
News Focus
Post# of 257257
Next 10
Followers 842
Posts 122795
Boards Moderated 10
Alias Born 09/05/2002

Re: DewDiligence post# 206058

Thursday, 02/23/2017 12:17:07 PM

Thursday, February 23, 2017 12:17:07 PM

Post# of 257257
RETA starts phase-2/3 trial in Alport syndrome:

http://finance.yahoo.com/news/reata-announces-initiation-phase-2-141500386.html

Reata expects data from the Phase 2 portion of the trial to be available, and to decide on entering the Phase 3 portion, by year-end 2017.

‘poorgradstudent’ is bearish on this program and on the drug candidate, bardoxolone in general.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now